The Oxidative DNA Damage Marker 8-OHdG Indicates No Clear Association to Newly Detected Breast Cancer in Women

Abstract

The role of 8-hydroxydeoxyguanosine (8-OHdG) as a biomarker in breast cancer remains controversial with conflicting results across studies. This case-control study aimed at comparing serum 8-OHdG levels between breast cancer patients and healthy controls, and examine associations with clinical characteristics. Thus, 71 Iraqi women (47 newly diagnosed, treatment-naïve breast cancer patients and 24 controls) were used from November 2024 to June 2025. Demographic data and lifestyle factors were collected through structured questionnaires. No significant difference was found in median 8-OHdG levels between breast cancer patients and controls. No correlations were observed between 8-OHdG and age, BMI, tumor grade, or hormone receptor status. Our findings suggest that 8-OHdG may not serve as a general screening biomarker for breast cancer, as its levels were comparable across all clinical and pathological parameters examined.

Keywords

• 8-hydroxy-2
• breast neoplasms
• oxidative stress
• tumor biomarkers

References

1. Al-Tameemi HK, Abdullah DA, Al-Baldawy MT, Abid HA, Al-Saffar OB, Al-Gazali HR (2025). Comprehensive analysis of six biomarkers expression in early-stage breast cancer: A crosssectional study. Dubai Med J. 8: 57–72. https://doi.org/10.18502/dmj.v8i1.18315
2. Gornitsky M, Velly AM, Mohit S et al. (2016). Altered levels of salivary 8-oxo-7-hydrodeoxyguanosine in breast cancer. JDR Clin Transl Res. 1: 171–177. https://doi.org/10.1177/2380084416642197
3. Graille M, Wild P, Sauvain J-J, Hemmendinger M, Guseva Canu I, Hopf NB (2020). Urinary 8-OHDG as a biomarker for oxidative stress: A systematic literature review and meta-analysis. Int J Mol Sci. 21: 3743. https://doi.org/10.3390/ijms21113743
4. Himmetoglu S, Dincer Y, Ersoy YE, Bayraktar B, Celik V, Akcay T (2009). DNA oxidation and antioxidant status in breast cancer. J Investig Med. 57: 720–723. https://doi.org/10.2310/JIM.0b013e3181adfb5b
5. Huyut Z, Uçar B, Yıldızhan K, Altındağ F, Huyut MT (2024). Effect of abemaciclib and curcumin administration on sex hormones, reproductive functions, and oxidative DNA expression in rats. Biotech Histochem. 99: 339–347. https://doi.org/10.1080/10520295.2024.2389524
6. Jakovcevic D, Dedic-Plavetic N, Vrbanec D, Jakovcevic A, Jakic-Razumovic J (2015). Breast cancer molecular subtypes and oxidative DNA damage. Appl. Immunohistochem. Mol Morphol. 23: 696–703. https://doi.org/10.1097/PAI.0000000000000135
7. Jelic MD, Mandic AD, Maricic SM, Srdjenovic BU (2021). Oxidative stress and its role in cancer. J Cancer Res Ther. 17: 22–28. https://doi.org/10.4103/jcrt.JCRT_862_16
8. Kasai H, Kawai K, Li Y (2008). Analysis of 8-OH-dG and 8-OH-Gua as biomarkers of oxidative stress. Genes Environ. 30: 33–40. https://doi.org/10.3123/jemsge.30.33

9. Lee K-H, Shu X-O, Gao Y-T et al. (2010). Breast cancer and urinary biomarkers of polycyclic aromatic hydrocarbon and oxidative stress in the Shanghai Women’s Health Study. Cancer Epidemiol Biomarkers Prev. 19: 877–883. https://doi.org/10.1158/1055-9965.EPI-09-1098
10. Li D, Zhang W, Zhu J et al. (2001). Oxidative DNA damage and 8‐ hydroxy‐2‐deoxyguanosine DNA glycosylase/apurinic lyase in human breast cancer. Mol Carcinog. 31: 214–223. https://doi.org/10.1002/mc.1056
11. Liu Z, Yi J, Liu F (2021). The expression and significance of 8- hydroxydeoxyguanosine in breast cancer patients’ blood, urine and cancer tissue. Trends Immunother. 5: 36. https://doi.org/10.24294/ti.v5.i2.1.1374
12. Loft S, Fischer‐Nielsen A, Jeding IB, Vistisen K, Poulsen HE (1993). 8‐hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J Toxicol Environ Health 40: 391–404. https://doi.org/10.1080/15287399309531806
13. Musarrat J, Arezina-wilson J, Wani AA (1996). Prognostic and aetiological relevance of 8-hydroxyguanosine in human breast carcinogenesis. Eur J Cancer 32: 1209–1214. https://doi.org/10.1016/0959-8049(96)00031-7
14. Nour Eldin EEM, El-Readi MZ, Nour Eldein MM et al. (2019). 8-Hydroxy-2’-deoxyguanosine as a discriminatory biomarker for early detection of breast cancer. Clin Breast Cancer. https://doi.org/10.1016/j.clbc.2018.12.013
15. Ock C-Y (2012). 8-Hydroxydeoxyguanosine: Not mere biomarker for oxidative stress, but remedy for oxidative stress-implicated gastrointestinal diseases. World J Gastroenterol. 18: 302. https://doi.org/10.3748/wjg.v18.i4.302
16. Rossner P, Gammon MD, Terry MB et al. (2006). Relationship between Urinary 15-F2t-Isoprostane and 8-Oxodeoxyguanosine Levels and Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. 15:, 639– 644. https://doi.org/10.1158/1055-9965.EPI-05-0554
17. Sova H (2014). Oxidative stress in breast and gynaecological carcinogenesis. University of Oulu, Oulu, Finland.
18. Sova H, Jukkola-Vuorinen A, Puistola U, Kauppila S, Karihtala P (2010). 8-Hydroxydeoxyguanosine: A new potential independent prognostic factor in breast cancer. Br J Cancer. https://doi.org/10.1038/sj.bjc.6605565
19. Valavanidis A, Vlachogianni T, Fiotakis C (2009). 8-hydroxy-2′ - deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Heal Part C 27: 120–139. https://doi.org/10.1080/10590500902885684
20. Yağcı T, Çınar R, Altıner Hİ, Dündar R, Yıldızhan K (2025). The role of TRPM2 channel in doxorubicin-induced cell damage in laryngeal squamous cancer cells. Dokl Biochem Biophys. 520: 123–129. https://doi.org/10.1134/S1607672924601070
21. Yahia S, Tahari Z, Medjdoub A et al. (2025). Expression analysis of oxidative stress markers 8-hydroxydeoxyguanosine and protein carbonyl in breast cancer and their associations with certain immunological and tumor markers. Asian Pac J Cancer Prev. 26: 639–646. https://doi.org/10.31557/APJCP.2025.26.2.639
22. Yaseen SM, Abid HA, Al-Obaidi MA (2020). Disturbed levels of nonenzymatic antioxidants and malondialdehyde among makeup users. J Tech. 2: 42–48. https://doi.org/10.51173/jt.v2i1.166